Cognoa: Funding, Investors & Team (Sep 2026)
A pediatric behavioral health business called Cognoa is creating digital diagnostics and therapies to help with the earlier detection and treatment of mental health issues like autism. Our goal is to better the long-term results for families and kids who are at risk of developmental delays. Our flagship products, the first prescription digital treatment for autistic children and the first digital diagnosis tool for autism, have both been given the FDA's Breakthrough Device designation. Cognoa's product pipeline will be able to address more unmet needs, including ADHD and anxiety, thanks to the company's AI technology platform. Cognoa intends to market Canvas DxTM as its tool for diagnosing autism. Visit CanvasDx.com for more details and to sign up for availability updates on Canvas DxTM.
Cognoa has raised $73.1M across 1 funding round on record, the most recent a Series B of $73.1M announced in Nov 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cognoa Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Cognoa Funding Rounds
Cognoa Founders and Leadership Team
Contact details for the Cognoa team: 1 of 1 has an email address on file.
Start 14-day free trial →Cognoa Funding Compared to Other Biotechnology Startups
Cognoa's latest round of $73.1M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cognoa in Biotechnology and Palo Alto
Companies Similar to Cognoa
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Cognoa Funding FAQs
What does Cognoa do?
A pediatric behavioral health business called Cognoa is creating digital diagnostics and therapies to help with the earlier detection and treatment of mental health issues like autism. Our goal is to better the long-term results for families and kids who are at risk of developmental delays. Our flagship products, the first prescription digital treatment for autistic children and the first digital diagnosis tool for autism, have both been given the FDA's Breakthrough Device designation. Cognoa's product pipeline will be able to address more unmet needs, including ADHD and anxiety, thanks to the company's AI technology platform. Cognoa intends to market Canvas DxTM as its tool for diagnosing autism. Visit CanvasDx.com for more details and to sign up for availability updates on Canvas DxTM.
How much funding has Cognoa raised?
Cognoa has raised $73.1M across 1 round on record. The most recent is a Series B of $73.1M announced in Nov 2022.
When did Cognoa last raise funding?
Cognoa's most recent funding round on record is a Series B of $73.1M, announced in Nov 2022.
Who founded Cognoa?
FundedIQ lists Dennis Wall (Founder) at Cognoa.
Where is Cognoa headquartered?
Cognoa is based in Palo Alto, California, United States.
How many employees does Cognoa have?
Cognoa is in the 51-100 employee band.
How does Cognoa's funding compare to other Biotechnology startups?
Cognoa's latest round of $73.1M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Cognoa Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cognoa is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.